uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Motor Unit Number Index (MUNIX) detects motor neuron loss in pre-symptomatic muscles in Amyotrophic Lateral Sclerosis
Kantonsspital St Gallen, ALS Clin, Neuromuscular Dis Unit, Rorschacherstr 95, CH-9007 St Gallen, Switzerland..
Med Coll Wisconsin, Milwaukee, WI 53226 USA..
Kantonsspital St Gallen, ALS Clin, Neuromuscular Dis Unit, Rorschacherstr 95, CH-9007 St Gallen, Switzerland..
Univ Lisbon, Hosp Santa Maria, Fac Med, Inst Mol Med,Dept Neurosci, P-1699 Lisbon, Portugal..
Show others and affiliations
2017 (English)In: Clinical Neurophysiology, ISSN 1388-2457, E-ISSN 1872-8952, Vol. 128, no 3, p. 495-500Article in journal (Refereed) Published
Abstract [en]

Objective: Motor Unit Number Index (MUNIX) is a quantitative neurophysiological measure that provides an index of the number of lower motor neurons supplying a muscle. It reflects the loss of motor neurons in patients with Amyotrophic Lateral Sclerosis (ALS). However, it is unclear whether MUNIX also detects motor unit loss in strong, non-wasted muscles. Methods: Three centres measured MUNIX in 49 ALS patients every three months in six different muscles (abductor pollicis brevis, abductor digiti minimi, biceps brachii, tibialis anterior, extensor digitorum brevis, abductor hallucis) on the less affected side. The decline of MUNIX in initially non-wasted, clinically strong muscles (manual muscle testing, MMT grade 5) was analysed before and after onset of weakness. Results: In 49 subjects, 151 clinically strong muscles developed weakness and were included for analysis. The average monthly relative loss of MUNIX was 5.0% before and 5.6% after onset of weakness. This rate of change was significantly higher compared to ALS functional rating scale (ALSFRS-R) and compound muscle action potential (CMAP) change over 12 months prior to the onset of muscle weakness (p = 0.024). Conclusion: MUNIX is an electrophysiological marker that detects lower motor neuron loss in ALS, before clinical weakness becomes apparent by manual muscle testing. Significance: This makes MUNIX a good biomarker candidate for disease progression and possibly pharmacodynamics responds.

Place, publisher, year, edition, pages
ELSEVIER IRELAND LTD , 2017. Vol. 128, no 3, p. 495-500
Keywords [en]
MUNIX, Pre-symptomatic ALS, Biomarker, Multicentre, ALSFRS-R
National Category
Neurology
Identifiers
URN: urn:nbn:se:uu:diva-320836DOI: 10.1016/j.clinph.2016.11.026ISI: 000397962900016PubMedID: 28043769OAI: oai:DiVA.org:uu-320836DiVA, id: diva2:1091432
Funder
EU, European Research CouncilAvailable from: 2017-04-26 Created: 2017-04-26 Last updated: 2017-04-26Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records BETA

Stålberg, Erik

Search in DiVA

By author/editor
Stålberg, Erik
By organisation
Clinical Neurophysiology
In the same journal
Clinical Neurophysiology
Neurology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 275 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf